共 106 条
[1]
Young WF(2019)Diagnosis and treatment of primary aldosteronism: practical clinical perspectives J. Intern. Med. 285 126-148
[2]
Mulatero P(2016)Guidelines for primary aldosteronism: uptake by primary care physicians in europe J. Hypertens. 34 2253-2257
[3]
Rossi E(2017)Diagnostic rate of primary aldosteronism in emilia-romagna, Northern Italy, during 16 years (2000–2015) J. Hypertens. 35 1691-1697
[4]
Perazzoli F(2012)Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies—a review of the current literature Horm. Metab. Res. 44 157-162
[5]
Negro A(2016)The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline J. Clin. Endocrinol. Metab. 101 1889-1916
[6]
Magnani A(2017)Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice J. Am. Coll. Cardiol. 69 1811-1820
[7]
Hannemann A(2020)The unrecognized prevalence of primary aldosteronism: a cross-sectional study Ann. Intern. Med. 173 10-20
[8]
Wallaschofski H(2005)Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism J. Am. Coll. Cardiol. 45 1243-1248
[9]
Funder JW(2018)Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis Lancet Diabetes Endocrinol. 6 41-50
[10]
Monticone S(2007)Aldosterone and end-organ damage Clin. Sci. 113 267-278